Rituximab to Treat Severe Hemophilia A
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cassandra Josephson, MD
Children's Healthcare of Atlanta
Principal Investigator - Charles Sexauer, MD
University of Oklahoma
Principal Investigator - Cindy Leissinger, MD
Tulane University Health Sciences Center
Principal Investigator - Diane Nugent, MD
Children's Hospital of Orange County
Principal Investigator - Ellis Neufeld, MD
Boston Children's Hospital
Principal Investigator - Janna Journeycake, MD
University of Texas Southwestern Medical Center
Principal Investigator - Joan Gill, MD
Versiti Blood Health
Principal Investigator - Keith McCrae, MD
University Hospital of Cleveland
Principal Investigator - Leonard Valentino, MD
Rush University Medical Center
Principal Investigator - Leslie Raffini, MD
Children's Hospital of Philadelphia
Principal Investigator - Marcella Torres, MD
Cook Children's Medical Center
Principal Investigator - Margaret Ragni, MD
Hemophilia Center of Western Pennsylvania
Principal Investigator - Nigel Key, MD
University of North Carolina
Principal Investigator - Susan F. Assmann, PhD
NERI
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Orange County
Orange, California, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Tulane University Health Sciences Center
New Orleans, Louisiana, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Unc at Chapel Hill Hospital
Chapel Hill, North Carolina, United States
- University Hospital of Cleveland
Cleveland, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Hemophilia Center of Western Pennsylvania
Pittsburgh, Pennsylvania, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Comprehensive Center for Bleeding Disorders
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2006
- Primary completion
- 30 Nov 2010
- Completion
- 31 Jan 2012
- Last update posted
- 11 Jun 2013
- Registered enrollment
- 23
- Registry id
- NCT00331006
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.